NCT02012556View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
HIV
Interventions
DRUG

Tesamorelin

Trial Locations (1)

H3X 2H9

Anapharm Montreal, Montreal

Sponsors

Lead Sponsor

Theratechnologies
All Listed Sponsors
lead

Theratechnologies

INDUSTRY

NCT02012556 - Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients | Biotech Hunter | Biotech Hunter